Compass Therapeutics
CMPX
#7794
Rank
A$0.51 B
Marketcap
A$2.89
Share price
7.25%
Change (1 day)
-11.05%
Change (1 year)

Earnings for Compass Therapeutics (CMPX)

Earnings in 2025 (TTM): -A$0.12 Billion

According to Compass Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$78.98 Million a decrease over its 2023 earnings that were of -A$70.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Compass Therapeutics from 2020 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.12 Billion41.04%
2024 -A$78.98 Million12.43%
2023 -A$70.25 Million24.79%
2022 -A$56.29 Million-50.67%
2021 -A$0.12 Billion186.46%
2020 -A$39.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.2 Billion 100.22%๐Ÿ‡บ๐Ÿ‡ธ USA